# Clustering Approach 3 : RPPA_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0113405215173863	Range of duration = 1.08 to 48.79, nDeath = 10, nCensor = 5
2	AGE	t-test	0.149144142430059	Range of values = 31 to 85, Mean = 57.5333, StdDev = 16.6893
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.794527433788131	nTypes = 3 (DISTANT METASTASIS/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)/REGIONAL LYMPH NODE), nPatients = 5/2/23
4	GENDER	Fisher's exact test	0.4664001332667	nTypes = 2 (FEMALE/MALE), nPatients = 11/19
5	LYMPH.NODE.METASTASIS	Chi-square test	0.915162219745281	nTypes = 5 (N0/N1A/N1B/N2B/N3), nPatients = 16/2/4/1/4, nMissing = 3
6	TUMOR.STAGECODE	t-test	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 30
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.673320303327479	nTypes = 12 (I OR II NOS/STAGE I/STAGE IA/STAGE IB/STAGE II/STAGE IIA/STAGE IIB/STAGE III/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/3/3/3/3/2/1/1/1/3/5/1, nMissing = 3
